Supplementary Figure 3. Prevalences of Vaccine-Induced, Infection-Induced, and Hybrid Immunity Against SARS-CoV-2 Among Blood Donors Aged ≥16 Years, by Race and Ethnicity — United States, April 2021–September 2022

Details

• Alternative Title:
  Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status — United States, March 2021–September 2022: Supplementary Figure 3. Prevalences of Vaccine-Induced, Infection-Induced, and Hybrid Immunity Against SARS-CoV-2 Among Blood Donors Aged ≥16 Years, by Race and Ethnicity — United States, April 2021–September 2022
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Subjects:
  Disease Notification Public Health Public Health Surveillance
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2023; v. 72, no. 22
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  1 pdf page
• Volume:
  72
• Issue:
  22
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:fd3380f1b40cb08b4f91bc2edb030c3674e39b86b9c4969eb956006cd726a8899da6683794735029240aec8b67f0ca3be705267f0af69039d693673b050314ea
• Download URL:
  https://stacks.cdc.gov/view/cdc/128680/cdc_128680_DS1.pdf
• File Type:
  [PDF - 1009.43 KB ]